Ardent Health Partners (ARDT)
Ardent Health Partners Statistics
Share Statistics
Ardent Health Partners has 142.75M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 142.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 77.47% |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 231 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 1.74M, so 1.22% of the outstanding shares have been sold short.
| Short Interest | 1.74M |
| Short % of Shares Out | 1.22% |
| Short % of Float | 5.27% |
| Short Ratio (days to cover) | 4.09 |
Valuation Ratios
The PE ratio is 11.59 and the forward PE ratio is 6.39. Ardent Health Partners's PEG ratio is 0.03.
| PE Ratio | 11.59 |
| Forward PE | 6.39 |
| PS Ratio | 0.41 |
| Forward PS | 0.2 |
| PB Ratio | 1.6 |
| P/FCF Ratio | 19.12 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Ardent Health Partners has an Enterprise Value (EV) of 4.16B.
| EV / Sales | 0.7 |
| EV / EBITDA | 7.49 |
| EV / EBIT | 13.22 |
| EV / FCF | 32.65 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 1.5.
| Current Ratio | 1.94 |
| Quick Ratio | 1.82 |
| Debt / Equity | 1.5 |
| Debt / EBITDA | 4.11 |
| Debt / FCF | 17.9 |
| Interest Coverage | 6.19 |
Financial Efficiency
Return on Equity is 13.83% and Return on Invested Capital is 8.33%.
| Return on Equity | 13.83% |
| Return on Assets | 4.24% |
| Return on Invested Capital | 8.33% |
| Revenue Per Employee | $310.73K |
| Profits Per Employee | $10.96K |
| Employee Count | 19,200 |
| Asset Turnover | 1.2 |
| Inventory Turnover | 22.02 |
Taxes
| Income Tax | 63.35M |
| Effective Tax Rate | 17.45% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -0.35, so Ardent Health Partners's price volatility has been lower than the market average.
| Beta | -0.35 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 13.32 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 48.51 |
| Average Volume (20 Days) | 451.69K |
Income Statement
In the last 12 months, Ardent Health Partners had revenue of 5.97B and earned 210.34M in profits. Earnings per share was 1.59.
| Revenue | 5.97B |
| Gross Profit | 3.43B |
| Operating Income | 405.76M |
| Net Income | 210.34M |
| EBITDA | 555.92M |
| EBIT | 428.64M |
| Earnings Per Share (EPS) | 1.59 |
Balance Sheet
The company has 556.78M in cash and 2.28B in debt, giving a net cash position of -1.73B.
| Cash & Cash Equivalents | 556.78M |
| Total Debt | 2.28B |
| Net Cash | -1.73B |
| Retained Earnings | 365.8M |
| Total Assets | 4.96B |
| Working Capital | 887.33M |
Cash Flow
In the last 12 months, operating cash flow was 315.03M and capital expenditures -187.51M, giving a free cash flow of 127.52M.
| Operating Cash Flow | 315.03M |
| Capital Expenditures | -187.51M |
| Free Cash Flow | 127.52M |
| FCF Per Share | 0.89 |
Margins
Gross margin is 57.51%, with operating and profit margins of 6.8% and 3.53%.
| Gross Margin | 57.51% |
| Operating Margin | 6.8% |
| Pretax Margin | 6.09% |
| Profit Margin | 3.53% |
| EBITDA Margin | 9.32% |
| EBIT Margin | 6.8% |
| FCF Margin | 2.14% |
Dividends & Yields
ARDT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 8.63% |
| FCF Yield | 5.23% |
Analyst Forecast
The average price target for ARDT is $21, which is 67.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $21 |
| Price Target Difference | 67.1% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Scores
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 9 |